INS and COVID-19: Therefore, we can suggest that the deleterious effects of a preexisting IR (altered blood pressure, vascular dysfunction, inflammation, and thrombosis) are added to the cytokine storm produced by SARS-CoV-2, leading to greater severity in patients with COVID-19, in addition to the harmful effects of insulin on lung function.